Banati Richard B
Department of Neuropathology, Departments of Psychiatry, Molecular Neuropsychiatry, Charing Cross Hospital, Imperial College School of Medicine, and MRC Clinical Sciences Centre (PET Neurology), Hammersmith Hospital, London, United Kingdom.
Glia. 2002 Nov;40(2):206-217. doi: 10.1002/glia.10144.
In health, microglia reside as quiescent guardian cells ubiquitously, but isolated without any cell-cell contacts amongst themselves, throughout the normal CNS. In disease, however, they act as swift "sensors" for pathological events, including subtle ones without any obvious structural damage. Once activated, microglia show a territorially highly restricted involvement in the disease process. This property, peculiar to microglia, confers to them diagnostic value for the accurate spatial localisation of any active disease process, acute or chronic. In the brain, the isoquinoline PK11195, a ligand for the peripheral benzodiazepine binding site (PBBS), binds with relative cellular selectivity to activated, but not resting, microglia. Labelled with carbon-11, (R)-PK11195 and positron emission tomography (PET) have been used for the study of inflammatory and neurodegenerative brain disease in vivo. These studies demonstrate meaningfully distributed patterns of regional (11)C-PK11195 signal increases that correlate with clinically observed loss of function. Increased (11)C-PK11195 binding closely mirrors the histologically well-described activation of microglia in the penumbra of focal lesions, as well as in the distant, anterograde, and retrograde projection areas of the lesioned neural pathway. There is also some indication that in long-standing alterations of a neural network with persistent abnormal input, additional signals of glial activation may also emerge in transsynaptic areas. These data suggest that the injured brain is less static than commonly thought and shows subtle glial responses even in macroanatomically stable appearing regions. This implies that glial activation is not solely a sign of tissue destruction, but possibly of disease-induced adaptation or plasticity as well. Whilst further technological and methodological advances are necessary to achieve routine clinical value and feasibility, a systematic attempt to image glial cells in vivo is likely to furnish valuable information on the cellular pathology of CNS diseases and their progression within the distributed neural architecture of the brain.
在健康状态下,小胶质细胞作为静止的守护细胞普遍存在,但在整个正常中枢神经系统中彼此孤立,没有任何细胞间接触。然而,在疾病状态下,它们会作为病理事件的快速“传感器”,包括那些没有明显结构损伤的细微事件。一旦被激活,小胶质细胞在疾病过程中表现出在区域上高度受限的参与。小胶质细胞特有的这一特性赋予了它们对任何急性或慢性活动性疾病过程进行准确空间定位的诊断价值。在大脑中,异喹啉PK11195是外周苯二氮䓬结合位点(PBBS)的配体,它与活化的而非静止的小胶质细胞具有相对的细胞选择性结合。用碳-11标记的(R)-PK11195和正电子发射断层扫描(PET)已被用于体内炎症性和神经退行性脑疾病的研究。这些研究表明,区域[(11)C](R)-PK11195信号增加呈现出有意义的分布模式,与临床观察到的功能丧失相关。[(11)C](R)-PK11195结合增加紧密反映了组织学上详细描述的局灶性病变半暗带中小胶质细胞的活化,以及受损神经通路的远距离、顺行和逆行投射区域中的活化。也有一些迹象表明,在具有持续异常输入的神经网络的长期改变中,胶质细胞活化的额外信号也可能出现在跨突触区域。这些数据表明,受损的大脑比通常认为的更具动态性,即使在宏观解剖学上看似稳定的区域也会出现细微的胶质细胞反应。这意味着胶质细胞活化不仅是组织破坏的标志,也可能是疾病诱导的适应或可塑性的标志。虽然要实现常规临床价值和可行性还需要进一步的技术和方法进步,但在体内对胶质细胞进行成像的系统性尝试可能会提供有关中枢神经系统疾病细胞病理学及其在大脑分布式神经结构中进展的有价值信息。